Mupirocin calcium - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for mupirocin calcium and what is the scope of patent protection?

Mupirocin calcium is the generic ingredient in two branded drugs marketed by Glaxosmithkline, Alembic, Amneal, Encube, Glenmark Pharms Inc, Padagis Israel, and Taro, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for mupirocin calcium. Seven suppliers are listed for this compound.

Summary for mupirocin calcium

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	8
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	121
Clinical Trials:	3
Patent Applications:	6,556
What excipients (inactive ingredients) are in mupirocin calcium?	mupirocin calcium excipients list
DailyMed Link:	mupirocin calcium at DailyMed

Recent Clinical Trials for mupirocin calcium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Perrigo Company	Phase 3
National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Taro Pharmaceuticals USA	Phase 1

See all mupirocin calcium clinical trials

Pharmacology for mupirocin calcium

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for mupirocin calcium

D06AX	Other antibiotics for topical use
D06A	ANTIBIOTICS FOR TOPICAL USE
D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D	Dermatologicals

R01AX	Other nasal preparations
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

US Patents and Regulatory Information for mupirocin calcium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alembic	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213053-001	Nov 16, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	214811-001	Nov 15, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Israel	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	212465-001	Aug 3, 2022		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Encube	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213076-001	Aug 31, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Taro	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	207116-001	Apr 27, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for mupirocin calcium

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Glaxosmithkline	BACTROBAN	mupirocin calcium	CREAM;TOPICAL	050746-001	Dec 11, 1997	⤷ Sign Up	⤷ Sign Up
Glaxosmithkline	BACTROBAN	mupirocin calcium	OINTMENT;NASAL	050703-001	Sep 18, 1995	⤷ Sign Up	⤷ Sign Up
Glaxosmithkline	BACTROBAN	mupirocin calcium	CREAM;TOPICAL	050746-001	Dec 11, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.